MCTC Holdings Inc. (MCTC) CEO Praises Cannabis Inf
Post# of 112
(Total Views: 204)
Posted On: 12/23/2019 3:48:50 PM
MCTC Holdings Inc. (MCTC) CEO Praises Cannabis Infusion Technology Company’s Direction in Year-End Shareholder Letter
- MCTC Holdings Inc. is raising a toast to its advances and plans for 2020 in a year-end letter to shareholders that recaps the company’s management restructuring and change in strategy during the past year
- MCTC has filed for a fifth patent for its Hemp You Can Feel product line as it continues developing mechanisms for using microparticle and nanoparticle technology to make cannabinoid compound delivery to the bloodstream more effective
- The company is preparing to change its company identity to Cannabis Global, Inc., and to introduce several new direct product offerings based on its IP technologies, including glycosides and nanoparticles of lesser-known cannabinoids to be used possibly in appetite suppression and sleep product testing
MCTC Holdings Inc. (OTC: MCTC) Chief Executive Arman Tabatabaei has issued a year-end letter to shareholders, offering a holiday toast to company directors as it recaps MCTC’s advances since the passage of the 2018 U.S. Farm Bill last December and sets the stage for the coming year.
MCTC reorganized its management in May and redirected its budding strategy from hemp cultivation and post-harvest processing segment to the science of hemp extract and cannabinoid biodelivery, avoiding “many of the well-publicized issues currently being experienced in the hemp sectors” while whole-heartedly embracing the underserved market pertaining to how cannabinoids are best utilized by the human body, Tabatabaei states in his letter (http://nnw.fm/E3sJu).
“In only a few months, through our internal development efforts and through the efforts of our CROs (Contract Research Organizations) we have begun to make an impact within the cannabinoid sciences arena. … We think our cutting edge research and development work in the laboratory is just getting started,” Tabatabaei adds.
MCTC, which is in the process of changing its corporate identity to Cannabis Global, Inc., recently applied for its fifth patent to build on its research into ways of best using cannabinoids as a replacement for alcohol in many beverages, thereby avoiding many of the deleterious effects of alcohol on the human body while adding the potential wellness benefits of the cannabis plant.
The company’s research focuses on the development of efficient biodelivery mechanisms through microparticle and nanoparticle forms of MCTC’s trademarked “Hemp You Can Feel” technology. Such minuscule particles have long been utilized by the food and medical industries as carriers that can transmit desired chemicals’ properties on a direct route into the bloodstream instead of through the lengthy digestive tract and its substance filters (http://nnw.fm/yKtD9).
Laboratory results indicate Hemp You Can Feel brand technology makes some of the major cannabinoids virtually undetectable, exceeding MCTC’s expectations for infusing beverages, powders and liquid concentrates with substances at the lowest quantitative levels that are nevertheless able to provide effective results (http://nnw.fm/4kX3e).
“We recently started a project to produce nanoparticles of our Hemp You Can Feel (TM) technology and cannabinoid glycosides, the first phase of which is expected to be completed by the end of 2019,” Tabatabaei states. “Our next phases of research, and our most ambitious, is to create glycosides and nanoparticles of non-psychoactive tetrahydrocannabivarin (THC-V) and cannabinol (CBN), two lesser-known cannabinoids, to be used on appetite suppression and sleep product trials.”
As the company assumes its planned new corporate identity of Cannabis Global, Inc., during the coming year, it expects to announce several new direct product offerings based on its IP technologies, beginning in January.
Fortune Business Insights analysts predict the cannabis-infused beverage industry will obtain a valuation of $2.05 billion by 2026, rising exponentially from its 2018 level of $173.76 million (http://nnw.fm/SMQp8). Arcview Research issued a forecast that the overall cannabis-infused edibles market, including candies, chocolates and pills, may top $4.1 billion in Canada and the United States by 2022 (http://nnw.fm/8zBxU).
For more information, visit the company’s website at www.CannabisGlobalInc.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- MCTC Holdings Inc. is raising a toast to its advances and plans for 2020 in a year-end letter to shareholders that recaps the company’s management restructuring and change in strategy during the past year
- MCTC has filed for a fifth patent for its Hemp You Can Feel product line as it continues developing mechanisms for using microparticle and nanoparticle technology to make cannabinoid compound delivery to the bloodstream more effective
- The company is preparing to change its company identity to Cannabis Global, Inc., and to introduce several new direct product offerings based on its IP technologies, including glycosides and nanoparticles of lesser-known cannabinoids to be used possibly in appetite suppression and sleep product testing
MCTC Holdings Inc. (OTC: MCTC) Chief Executive Arman Tabatabaei has issued a year-end letter to shareholders, offering a holiday toast to company directors as it recaps MCTC’s advances since the passage of the 2018 U.S. Farm Bill last December and sets the stage for the coming year.
MCTC reorganized its management in May and redirected its budding strategy from hemp cultivation and post-harvest processing segment to the science of hemp extract and cannabinoid biodelivery, avoiding “many of the well-publicized issues currently being experienced in the hemp sectors” while whole-heartedly embracing the underserved market pertaining to how cannabinoids are best utilized by the human body, Tabatabaei states in his letter (http://nnw.fm/E3sJu).
“In only a few months, through our internal development efforts and through the efforts of our CROs (Contract Research Organizations) we have begun to make an impact within the cannabinoid sciences arena. … We think our cutting edge research and development work in the laboratory is just getting started,” Tabatabaei adds.
MCTC, which is in the process of changing its corporate identity to Cannabis Global, Inc., recently applied for its fifth patent to build on its research into ways of best using cannabinoids as a replacement for alcohol in many beverages, thereby avoiding many of the deleterious effects of alcohol on the human body while adding the potential wellness benefits of the cannabis plant.
The company’s research focuses on the development of efficient biodelivery mechanisms through microparticle and nanoparticle forms of MCTC’s trademarked “Hemp You Can Feel” technology. Such minuscule particles have long been utilized by the food and medical industries as carriers that can transmit desired chemicals’ properties on a direct route into the bloodstream instead of through the lengthy digestive tract and its substance filters (http://nnw.fm/yKtD9).
Laboratory results indicate Hemp You Can Feel brand technology makes some of the major cannabinoids virtually undetectable, exceeding MCTC’s expectations for infusing beverages, powders and liquid concentrates with substances at the lowest quantitative levels that are nevertheless able to provide effective results (http://nnw.fm/4kX3e).
“We recently started a project to produce nanoparticles of our Hemp You Can Feel (TM) technology and cannabinoid glycosides, the first phase of which is expected to be completed by the end of 2019,” Tabatabaei states. “Our next phases of research, and our most ambitious, is to create glycosides and nanoparticles of non-psychoactive tetrahydrocannabivarin (THC-V) and cannabinol (CBN), two lesser-known cannabinoids, to be used on appetite suppression and sleep product trials.”
As the company assumes its planned new corporate identity of Cannabis Global, Inc., during the coming year, it expects to announce several new direct product offerings based on its IP technologies, beginning in January.
Fortune Business Insights analysts predict the cannabis-infused beverage industry will obtain a valuation of $2.05 billion by 2026, rising exponentially from its 2018 level of $173.76 million (http://nnw.fm/SMQp8). Arcview Research issued a forecast that the overall cannabis-infused edibles market, including candies, chocolates and pills, may top $4.1 billion in Canada and the United States by 2022 (http://nnw.fm/8zBxU).
For more information, visit the company’s website at www.CannabisGlobalInc.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Cannabis Global, Inc. (CBGL) Stock Research Links
Scroll down for more posts ▼